Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

     
[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2002

     
[   ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from_____________to______________

Commission file Number: 0-30130

ATMI, Inc.

(Exact name of registrant as specified in its charter)
     
Delaware   06-1481060

 
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer Identification No.)
     
7 Commerce Drive, Danbury, CT   06810

 
(Address of principal executive offices)   (Zip Code)

203-794-1100
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No   

The number of shares outstanding of the registrant’s common stock as of November 4, 2002 was 30,641,011.

 


ATMI, INC.
Quarterly Report on Form 10-Q
For the Quarter Ended September 30, 2002

TABLE OF CONTENTS

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Operations
Consolidated Statements of Operations
Consolidated Statements of Cash Flows
Notes To Consolidated Interim Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Item 4. Controls and Procedures
PART II- OTHER INFORMATION
Item 1. Legal Proceedings
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
CERTIFICATIONS
CERTIFICATION


Table of Contents

           
      Page
Part I — Financial Information
       
 
       
Item 1. Financial Statements (unaudited)
       
 
Consolidated Balance Sheets
    3  
 
Consolidated Statements of Operations
    4  
 
Consolidated Statements of Cash Flows
    6  
 
Notes to Consolidated Interim Financial Statements
    7  
 
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    13  
 
       
Item 3. Quantitative and Qualitative Disclosures about Market Risk
    22  
 
       
Item 4. Controls and Procedures
    22  
 
       
Part II – Other Information
       
 
       
Item 1. Legal Proceedings
    23  
 
       
Item 6. Exhibits and Reports on Form 8-K
    23  
 
       
Signatures
    24  
 
       
Certifications
    25  
 
       
Exhibit
    29  

2


Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

ATMI, Inc.
Consolidated Balance Sheets
(in thousands, except per share data)

                     
        September 30,   December 31,
        2002   2001
       
 
Assets
  (unaudited)        
Current assets:
               
 
Cash and cash equivalents
  $ 48,773     $ 167,677  
 
Marketable securities
    111,872       42,817  
 
Accounts receivable, net of allowance for doubtful accounts of $1,746 in 2002, and $2,429 in 2001
    37,215       35,842  
 
Inventories, net
    30,810       39,042  
 
Deferred income taxes
    5,176       5,628  
 
Income taxes receivable
    15,500       9,200  
 
Other current assets
    16,545       15,682  
 
   
     
 
   
Total current assets
    265,891       315,888  
Property, plant, and equipment, net
    112,741       123,191  
Goodwill, net
    7,780       7,620  
Deferred income taxes
    9,958        
Other long-term assets, net
    17,221       12,357  
 
   
     
 
Total assets
  $ 413,591     $ 459,056  
 
   
     
 
Liabilities and stockholders’ equity
               
Current liabilities:
               
 
Accounts payable
  $ 7,386     $ 11,095  
 
Accrued liabilities
    16,513       15,912  
 
Accrued salaries and related benefits
    7,695       6,268  
 
Long-term debt, current portion
    1,501       15,862  
 
Capital lease obligations
    19       5,112  
 
Income taxes payable
    1,100       1,733  
 
Interest payable
    2,231       9  
 
Other current liabilities
    4,070       4,575  
 
   
     
 
   
Total current liabilities
    40,515       60,566  
Long-term debt, less current portion
    115,317       116,025  
Capital lease obligation, less current portion
    38        
Deferred income taxes
          1,849  
Other long-term liabilities
    300       602  
Commitments and contingencies
           
Stockholders’ equity:
               
 
Preferred stock, par value $.01: 2,000 shares authorized; none issued
    -–       -–  
 
Common stock, par value $.01: 50,000 shares authorized; 30,639 and 30,394 issued and outstanding in 2002 and 2001, respectively
    306       304  
 
Additional paid-in capital
    207,249       202,164  
 
Retained earnings
    50,006       78,889  
 
Accumulated other comprehensive loss
    (140 )     (1,343 )
 
   
     
 
Total stockholders’ equity
    257,421       280,014  
 
   
     
 
Total liabilities and stockholders’ equity
  $ 413,591     $ 459,056  
 
   
     
 

See accompanying notes.

3


Table of Contents

ATMI, Inc.
Consolidated Statements of Operations
(unaudited)
(in thousands, except per share data)

                   
      Three Months Ended September 30,
      2002   2001
Revenues
  $ 52,051     $ 39,727  
Cost of revenues
    35,530       26,408  
 
   
     
 
Gross profit
    16,521       13,319  
Operating expenses:
               
 
Research and development
    7,768       7,750  
 
Selling, general and administrative
    16,260       19,658  
 
Restructuring and other charges
    31,522       1,800  
 
   
     
 
 
    55,550       29,208  
 
   
     
 
Operating loss
    (39,029 )     (15,889 )
Interest income
    1,172       908  
Interest expense
    (1,491 )     (6 )
Other income (expense), net
    (770 )     747  
 
   
     
 
Loss before income taxes
    (40,118 )     (14,240 )
Income tax benefit
    (14,959 )     (5,215 )
 
   
     
 
Net loss
  $ (25,159 )   $ (9,025 )
 
   
     
 
Net loss per share-basic and assuming dilution
  $ (0.84 )   $ (0.30 )
 
   
     
 
Weighted average shares outstanding-basic and assuming dilution
    29,943       29,647  
 
   
     
 

See accompanying notes.

4


Table of Contents

ATMI, Inc.
Consolidated Statements of Operations
(unaudited)
(in thousands, except per share data)

                   
      Nine Months Ended September 30,
      2002   2001
Revenues
  $ 158,214     $ 172,035  
Cost of revenues
    98,749       95,928  
 
   
     
 
Gross profit
    59,465       76,107  
Operating expenses:
               
 
Research and development
    22,626       23,748  
 
Selling, general and administrative
    49,771       57,522  
 
Restructuring and other charges
    31,522       14,011  
 
   
     
 
 
    103,919       95,281  
 
   
     
 
Operating loss
    (44,454 )     (19,174 )
Interest income
    3,660       3,693  
Interest expense
    (5,233 )     (181 )
Other income, net
    181       7,425  
 
   
     
 
Loss before income taxes
    (45,846 )     (8,237 )
Income tax benefit
    (16,963 )     (3,114 )
 
   
     
 
Net loss
  $ (28,883 )   $ (5,123 )
 
   
     
 
Net loss per share-basic and assuming dilution
  $ (0.97 )   $ (0.17 )
 
   
     
 
Weighted average shares outstanding-basic and assuming dilution
    29,870       29,588  
 
   
     
 

See accompanying notes.

5


Table of Contents

ATMI, Inc.
Consolidated Statements of Cash Flows
(unaudited)
(in thousands)

                     
        Nine Months Ended September 30,
        2002   2001
       
 
Operating activities
               
Net loss
  $ (28,883 )   $ (5,123 )
Adjustments to reconcile net loss to net cash provided (used) by operating activities:
               
 
Depreciation and amortization
    14,566       11,922  
 
Restructuring and other charges
    31,522       14,011  
 
Provision for bad debt
    112       2,794  
 
Provision for inventory obsolescence & lower-of-cost or market
    4,732       1,806  
 
Deferred income taxes
    (11,664 )     98  
 
Tax benefit from nonqualified stock options
    826        
 
Realized gain on sale of marketable securities
    (958 )     (2,605 )
 
Realized loss on investments
    400       359  
 
Other
    15        
 
Changes in operating assets and liabilities:
               
   
Accounts receivable
    (1,484 )     26,771  
   
Inventory
    3,499       (2,451 )
   
Other assets
    550       (2,625 )
   
Accounts payable
    (3,709 )     (11,415 )
   
Accrued expenses
    976       (4,631 )
   
Income taxes
    (12,133 )     (4,072 )
   
Other liabilities
    1,415       (677 )
 
   
     
 
Net cash provided (used) by operating activities
    (218 )     24,162  
 
   
     
 
Investing activities
               
Capital expenditures
    (30,763 )     (58,124 )
Acquisitions and other equity investments
    (5,000 )     (8,500 )
Purchase of marketable securities
    (68,672 )     (36,639 )
Sale of marketable securities
    1,127       3,121  
 
   
     
 
Net cash used by investing activities
    (103,308 )     (100,142 )
 
   
     
 
Financing activities
               
Borrowings from loans, notes and bonds payable
          14,978  
Payments on loans, notes and bonds payable
    (15,069 )     (3,456 )
Payments on capital lease obligations
    (5,117 )     (2,174 )
Proceeds from exercise of stock options and employee stock purchase plan shares
    4,247       2,176  
 
   
     
 
Net cash provided (used) by financing activities
    (15,939 )     11,524  
 
   
     
 
Effects of exchange rate changes on cash
    561       (200 )
 
   
     
 
Net decrease in cash and cash equivalents
    (118,904 )     (64,656 )
Cash and cash equivalents, beginning of period
    167,677       127,786  
 
   
     
 
Cash and cash equivalents, end of period
  $ 48,773     $ 63,130  
 
   
     
 

See accompanying notes.

6


Table of Contents

ATMI, Inc.
Notes To Consolidated Interim Financial Statements
(unaudited)

1. Basis of Presentation

         The accompanying unaudited consolidated interim financial statements of ATMI, Inc. (“ATMI” or the “Company”) have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X and do not include all of the financial information and disclosures required by GAAP in the United States.

         In the opinion of the management of ATMI, the financial information contained herein has been prepared on the same basis as the audited consolidated financial statements contained in the Company’s Form 10-K, and includes adjustments (consisting of normal recurring adjustments) necessary to present fairly the unaudited quarterly results set forth herein. These unaudited consolidated interim financial statements should be read in conjunction with the December 31, 2001 audited consolidated financial statements and notes thereto included in the Company’s Form 10-K. The Company’s quarterly results have, in the past, been subject to fluctuation and, thus, the operating results for any quarter are not necessarily indicative of results for any future fiscal period.

         The consolidated Balance Sheet at December 31, 2001 has been derived from the audited financial statements at that date, but does not include all of the financial information and disclosures required by GAAP for complete financial statements.

         Certain prior year amounts have been reclassified to conform to the current year’s presentation.

2. Recent Accounting Pronouncements

         Effective January 1, 2002, ATMI has adopted the provisions of Statement of Financial Accounting Standards (“SFAS”) No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” which supersedes SFAS No. 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to be Disposed Of.” There was no material impact on ATMI’s financial position or results of operations as a result of adopting this new standard at the date of adoption. However, see Note 10 for a discussion of the impairment charge taken in the third quarter of 2002.

         In April 2002, the Financial Accounting Standards Board (FASB) issued SFAS No. 145, “Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections,” which will become effective for ATMI in fiscal year 2003. SFAS No. 145 changes the way gains and losses from extinguishment of debt are classified in the financial statements, and amends SFAS No. 13 to require that lease modifications having economic effects similar to sale-leaseback transactions be accounted for in the same manner as sale-leaseback transactions. ATMI anticipates that adoption of this standard will not materially impact the Company’s financial position or results of operations.

7


Table of Contents

         In June 2002, the FASB issued SFAS No. 146, “Accounting for Costs Associated with Exit or Disposal Activities,” which nullifies Emerging Issues Task Force (EITF) Issue No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity.” SFAS No. 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred, rather than on the date of commitment to an exit plan. The provisions of this Statement are effective for exit or disposal activities that are initiated after December 31, 2002. ATMI anticipates that adoption of this standard will not materially impact the Company’s financial position or results of operations.

3. Inventories

         Inventories are comprised of the following (in thousands):

                 
    September 30,   December 31,
    2002   2001
   
 
Raw materials
  $ 20,717     $ 25,093  
Work in process
    5,811       5,120  
Finished goods
    7,813       11,918  
 
   
     
 
 
    34,341       42,131  
Obsolescence and other reserves
    (3,531 )     (3,089 )
 
   
     
 
 
  $ 30,810     $ 39,042  
 
   
     
 

4. Goodwill and Other Intangibles

         The Company adopted the provisions of Statement of Financial Accounting Standards (SFAS) No. 142, “Goodwill and Other Intangible Assets” effective January 1, 2002. SFAS No. 142 changes the way companies account for goodwill in that goodwill is no longer amortized but instead will be tested for impairment at least annually. The Statements of Operations for the three and nine-month periods ended September 30, 2002 include the effect of adopting this new standard. The effect on reported net loss for the three and nine-month periods ended September 30, 2001 is shown in the following table (in thousands, except per share data):

                 
    Three Months Ended   Nine Months Ended
    Sept. 30, 2001   Sept. 30, 2001
   
 
Reported net loss
  $ (9,025 )   $ (5,123 )
Goodwill amortization, net of tax
    141       394  
 
   
     
 
Pro forma net loss
  $ (8,884 )   $ (4,729 )
Pro forma net loss per share—basic and assuming dilution
  $ (0.30 )   $ (0.16 )
 
   
     
 

8


Table of Contents

         Intangibles consisted of the following (in thousands):

                 
    September 30,   December 31,
    2002   2001
   
 
Goodwill, gross
  $ 11,348     $ 11,156  
Accumulated amortization
    (3,568 )     (3,536 )
 
   
     
 
Goodwill, net
  $ 7,780     $ 7,620  
 
   
     
 
Debt issuance costs, gross
  $ 4,257     $ 4,257  
Accumulated amortization
    (802 )     (171 )
 
   
     
 
Debt issuance costs, net
  $ 3,455     $ 4,086  
 
   
     
 
Other intangibles, gross
  $ 5,820     $ 2,485  
Accumulated amortization
    (1,646 )     (1,303 )
 
   
     
 
Other intangibles, net
  $ 4,174     $ 1,182  
 
   
     
 

5. Long-term Debt

         During the first quarter of 2002, the Company paid down the entire $13.5 million outstanding as of December 31, 2001 on the $20.0 million financing agreement entered into during the first quarter of 2001.

6. Leases

         During the first and second quarters of 2002, the Company paid down the entire $5.1 million of capital lease obligations outstanding as of December 31, 2001.

7. Other Comprehensive Loss

         The components of other comprehensive income (loss) are as follows (in thousands):

                                   
      Three Months Ended   Nine Months Ended
      September 30,   September 30,
      2002   2001   2002   2001
     
 
 
 
Net loss
  $ (25,159 )   $ (9,025 )   $ (28,883 )   $ (5,123 )
 
Cumulative translation adjustment
    438       939       1,524       197  
 
Unrealized gain (loss) on available-for-sale securities (net of taxes of $(592) and $118 in 2002 and $(502) and $473 in 2001)
    (966 )     (820 )     193       771  
 
Reclassification adjustment for realized gain on securities sold (net of taxes of $0 and $315 in 2002 and $507 and $637 in 2001)
          (827 )     (514 )     (1,040 )
 
   
     
     
     
 
Comprehensive loss
  $ (25,687 )   $ (9,733 )   $ (27,680 )   $ (5,195 )
 
   
     
     
     
 

9


Table of Contents

8. Segment Data

         Segment information is included under the caption “Segment Data” in Management’s Discussion and Analysis of Financial Condition and Results of Operations, which is incorporated herein by reference and is an integral part of these unaudited interim financial statements.

9. Income Taxes

         The former securityholders of the ADCS Group have agreed to indemnify the Company against losses arising out of possible tax liabilities of ADCS. As security for these potential liabilities, the former securityholders of ADCS deposited 700,000 shares of the Company’s common stock, which they received in connection with the Company’s acquisition of ADCS, into escrow. While the possible exposures are difficult to quantify, the Company believes that, regardless of the probability that liabilities will arise, the potential exposures range from $0 to $22 million depending on the resolution of the tax matter. Although the former securityholders of ADCS have agreed to indemnify the Company against losses arising out of such tax matters, any assessments, if ultimately determined against the Company, would result in a charge to the Company’s results of operations. During the second quarter of 1999, the Company was notified by the Internal Revenue Service of an assessment of $2.1 million for certain of these tax matters. The current value of the shares held in escrow provides indemnity towards the mid-range of the potential exposure. The Company continues to vigorously defend its position in these tax matters.

10. Restructuring and Other Charges

         The operating results for the nine months ended September 30, 2002 include an asset impairment charge of $34.6 million to recognize the impairment of assets in the Company’s gallium arsenide epitaxial services business in Phoenix, Arizona, due to deteriorating market conditions in this product line, of which $3.1 million is included in cost of revenues related to a write-down of inventory. Assets in the line of business have been written down to their fair value, less estimated costs of disposal, using estimated prices for similar assets as the basis for determining fair value. Excluding the inventory write-down, the impairment charge of $31.5 million is related to long-lived assets, including deposits on fixed assets. The Company intends to withdraw from this business by virtue of a sale or partnership. All of the impaired assets are in the Technologies segment.

         The operating results for the nine months ended September 30, 2001 include two restructuring charges: the first was a $12.8 million charge for severance and other costs associated with a restructuring initiative, of which $0.6 million is included in cost of revenues related to a write-down of inventory. The second charge occurred in the third quarter of 2001 for $1.8 million for severance related costs associated with a restructuring charge. The second initiative became necessary as a result of the severe decline in end-use semiconductor device demand.

         The restructuring initiatives include severance costs of $5.4 million, including the third quarter 2001 initiative of $1.8 million, and represent a reduction of approximately 21% of the Company’s worldwide workforce, including operations, sales and marketing, and other administrative employees. All of the affected employees had left their positions by June 30, 2002. These initiatives involve a number of actions intended to improve productivity and align the Company’s organization more closely with its customers. The restructuring initiatives and other

10


Table of Contents

charges also include $9.2 million for plant closings, lease termination fees, and various other asset write-offs or write-downs. Management anticipates that all restructuring costs will be paid by December 31, 2002, except for ongoing lease costs for exited facilities, which are expected to be paid over the remaining lease terms.

11


Table of Contents

         The following tables set forth the activity in the restructuring accruals, which are included in accrued liabilities, as of September 30, 2002 (in thousands):

                         
Accrual – Q1 2001 Restructuring   Severance   Other Charges   Total Accrual

 
 
 
Balance January 1, 2001
  $     $     $  
Restructuring charge
    3,599       9,198       12,797  
Cash payments
    (3,299 )     (280 )     (3,579 )
Write offs & write downs
          (7,994 )     (7,994 )
 
   
     
     
 
Balance December 31, 2001
  $ 300     $ 924     $ 1,224  
Cash payments
    (245 )     (576 )     (821 )
Write offs & write downs
          (40 )     (40 )
 
   
     
     
 
Balance September 30, 2002
  $ 55     $ 308     $ 363  
 
   
     
     
 
                         
Accrual – Q3 2001 Restructuring   Severance   Other Charges   Total Accrual

 
 
 
Balance January 1, 2001
  $     $     $  
Restructuring charge
    1,800             1,800  
Cash payments
    (1,080 )           (1,080 )
 
   
     
     
 
Balance December 31, 2001
  $ 720     $     $ 720  
Cash payments
    (720 )           (720 )
 
   
     
     
 
Balance September 30, 2002
  $     $     $  
 
   
     
     
 

11. Other Income

         The first nine months of 2002 results include a gain of approximately $1.0 million from the sale of available-for-sale securities, offset by write-downs of approximately $0.4 million for other-than-temporary declines in fair value of other available-for-sale securities and $0.4 million of amortization on bond premiums.

         In July 1999, ATMI filed suit against a company, alleging infringement of certain liquid delivery system patents. Later in 1999, that company filed suit against ATMI alleging infringement of a particular semiconductor process patent. In March 2001, an agreement was reached that addressed the settlement of both claims. Although the terms of the settlement remain confidential, ATMI received a payment in the settlement, which has been recorded in the 2001 financial statements as other income, net of related expenses. During the second and third quarters of 2001, the Company recognized a gain of approximately $2.6 million from the sale of available-for-sale securities, offset by a write-down of approximately $0.4 million for other-than-temporary declines in fair value of other available-for-sale securities.

12


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

         ATMI is a leading supplier of materials, equipment and related services used worldwide in the manufacture of semiconductor devices. ATMI specifically targets the “front-end” semiconductor materials market. This market includes the processes used to convert a bare silicon wafer into a fully functional wafer that contains many copies of a semiconductor device or “chip”. To complete the manufacturing process, this functional wafer is taken through a “back-end” manufacturing process that includes wafer dicing into chips, packaging and testing. ATMI’s customers include most of the leading semiconductor manufacturers in the world.

         ATMI has organized its operations along two business segments: Materials and Technologies. The Materials segment provides products that are used in the semiconductor manufacturing process and related packaging and delivery systems. The Technologies segment provides products and services that sense and environmentally control these materials while also providing specialized thin film deposition and outsourced parts cleaning and tool maintenance services to semiconductor device manufacturers. The Technologies segment also includes ATMI’s venture and government funded research and development activities.

         The semiconductor industry, in general, and the semiconductor equipment industry, in particular, have been highly cyclical and have experienced periods of overcapacity at various times, resulting in significantly reduced demand for semiconductor materials, capital equipment and wafer processing services. In the past year and a half, the semiconductor industry has experienced a severe downturn of unprecedented magnitude. However, wafer starts have shown signs of improvement in 2002, although the rate of improvement slowed considerably in the third quarter and remains about 6% below November 2000 peak levels. Industry equipment orders in September 2002 were 62% lower than peak levels in September 2000, with a decline in order activity experienced in the third quarter of 2002. ATMI’s operating results have been impacted by the industry downturn, especially with regard to its product lines that track industry manufacturing capacity. The second and third quarters of 2002 showed an increase in materials demand compared with the same quarters a year ago, as overall sales increased 16% versus the same two quarters in the previous year. However, lack of visibility remains and the level of recovery in the near term is uncertain. With regard to capital equipment spending, there remains substantial over-capacity on a global basis. Management believes that the likelihood of significant advanced technology capital equipment spending due to capacity expansion is low in the near term.

13


Table of Contents

Results of Operations

         The following table sets forth selected financial data as a percentage of total revenues for the periods indicated:

                                     
        Three Months Ended   Nine Months Ended
        September 30,   September 30,
        2002   2001   2002   2001
       
 
 
 
Revenues
    100.0 %     100.0 %     100.0 %     100.0 %
Cost of revenues
    68.3       66.5       62.4       55.8  
 
   
     
     
     
 
Gross profit
    31.7       33.5       37.6       44.2  
Operating expenses:
                               
 
Research and development
    14.9       19.5       14.3       13.8  
 
Selling, general and administrative
    31.2       49.5       31.5       33.4  
 
Restructuring and other charges
    60.6       4.5       19.9       8.1  
 
   
     
     
     
 
   
Total operating expenses
    106.7       73.5       65.7       55.3  
 
   
     
     
     
 
Operating loss
    (75.0 )     (40.0 )     (28.1 )     (11.1 )
Other income (loss), net
    (2.0 )     4.2       (0.9 )     6.3  
 
   
     
     
     
 
Loss before income taxes
    (77.0 )     (35.8 )     (29.0 )     (4.8 )
Income tax benefit
    (28.7 )     (13.1 )     (10.7 )     (1.8 )
 
   
     
     
     
 
Net loss
    (48.3 %)     (22.7 %)     (18.3 %)     (3.0 %)
 
   
     
     
     
 

Segment Data

         ATMI has two reportable operating segments: Materials and Technologies. The Company evaluates performance and allocates resources based on segment operating profit or loss, excluding non-recurring expenses, interest, other income or expense, and income taxes. The accounting policies of the reportable operating segments are the same as those described in the summary of significant accounting policies in the Company’s Consolidated Financial Statements contained in its Annual Report on Form 10-K for the year ended December 31, 2001. Intercompany sales are not material between operating segments. The general corporate assets include primarily cash, cash equivalents, marketable securities, goodwill and other long-term assets.

         The following tables provide reported results for each of these segments for the three and nine-month periods ended September 30 (in thousands):

                                 
    Three Months Ended   Nine Months Ended
Revenues   2002   2001   2002   2001

 
 
 
 
Materials
  $ 32,500     $ 21,833     $ 98,038     $ 88,261  
Technologies
    19,551       17,894       60,176       83,774  
 
   
     
     
     
 
Consolidated Revenues
  $ 52,051     $ 39,727     $ 158,214     $ 172,035  
 
   
     
     
     
 

14


Table of Contents

                                 
    Three Months Ended   Nine Months Ended
Operating Income (loss)   2002   2001   2002   2001

 
 
 
 
Materials
  $ 4,874     $ (1,049 )   $ 17,090     $ 13,356  
Technologies
    (12,381 )     (13,040 )     (30,022 )     (18,519 )
Restructuring and other charges (1)
    (31,522 )     (1,800 )     (31,522 )     (14,011 )
 
   
     
     
     
 
Consolidated operating loss
  $ (39,029 )   $ (15,889 )   $ (44,454 )   $ (19,174 )
 
   
     
     
     
 


(1)   The entire 2002 charge relates to the Technologies segment. Approximately $0.8 million and $1.0 million of the third quarter 2001 restructuring charge relate to the Materials and Technologies segments, respectively. Approximately $6.0 million and $8.0 million of the restructuring charge in the first nine months of 2001 relate to the Materials and Technologies segments, respectively.

         The following table provides reported balance sheet data for each of the segments:

                 
    September 30,   December 31,
Identifiable Assets   2002   2001

 
 
Materials
  $ 109,589     $ 98,893  
Technologies
    94,336       134,920  
General Corporate Assets
    209,666       225,243  
 
   
     
 
Total consolidated assets
  $ 413,591     $ 459,056  
 
   
     
 

Comparison of Three Months Ended September 30, 2002 and 2001

         Revenues. Total revenues increased 31.0% to approximately $52.1 million in the three months ended September 30, 2002 from approximately $39.7 million in the same period in 2001. The increase in revenues in the current quarter versus the prior year quarter was primarily attributable to volume increases across product lines in both segments of the business, as wafer starts and capital equipment spending increased compared to the prior year quarter. Revenues in the Materials segment increased 48.9% in the third quarter of 2002 compared to the same quarter a year ago, driven by stronger demand for SDS® products, high purity packaging products, and materials for advanced interconnect device manufacturing. Revenues in the Technologies segment increased 9.3% in the third quarter of 2002 compared to the same quarter a year ago due to strong demand for environmental treatment equipment and spare parts, despite reduced demand for thin film deposition services and life safety equipment.

         Gross Profit. Gross profit increased 24.0% to approximately $16.5 million in the quarter ended September 30, 2002 from approximately $13.3 million in the same quarter in 2001. Gross margin in the three-month period ended September 30, 2002 was 31.7% of revenues, compared to 33.5% in the same three-month period a year ago. During the quarter ended September 30, 2002, the Company recorded a special charge of $3.1 million to write down inventory in its gallium arsenide expitaxial services business, due to deteriorating market conditions in this business. During the quarter ended September 30, 2001, the Company recorded a special charge of $1.1 million to write down inventory in its Emosyn smartcard venture, as a result of previous production costs from its Asian foundry being higher than market pricing. Excluding these special charges, gross margin was 37.7% of revenues in the current quarter, compared to 36.3% in the same three-month period a year ago. The gross profit increase in the third quarter of 2002 versus the same quarter a year ago was driven mainly by volume increases in the product lines discussed above,

15


Table of Contents

partially offset by management’s decision at the beginning of 2002 to redirect certain engineering and support activities to focus on service agreements. As part of ATMI’s business realignment efforts that it announced and executed during the course of the past year and a half, ATMI consolidated several of its formerly autonomous business units, and certain engineering and support activities were redirected to provide field service, warranty and other customer and maintenance services which are classified as cost of revenues instead of research and development. If these engineering and support activities had been redirected to cost of revenues in the quarter ended September 30, 2001, gross margin would have been 30.9% rather than 33.5%. Alternatively, had these costs not been redirected, gross margin would have been 34.7% in the current quarter rather than 31.7%, as reported.

         Research and Development Expenses. Research and development expenses remained flat at $7.8 million in the three months ended September 30, 2002 compared to the same three-month period a year ago, mainly as a result of the redirection of certain engineering and support activities in the current-year quarter, as discussed above, compared to the same period in 2001. If these engineering and support activities had not been redirected in the third quarter of 2002, research and development expense would have increased 19.9% compared to the same quarter a year ago, due to increased strategic research and development spending on advanced interconnect production processes and increased research spending in the Emosyn smartcard venture. As a percentage of revenues, research and development expenses decreased to 14.9% in the three months ended September 30, 2002 from 19.5% in the same three-month period of 2001, driven mainly by the redirection of certain engineering and support activities, as discussed above, and the increase in revenues in the current-year quarter as compared to the same three-month period of 2001.

         Selling, General and Administrative Expenses. Selling, general and administrative expenses declined 17.3% to $16.3 million in the third quarter of 2002 compared to $19.7 million in the same quarter a year ago, as a result of a full quarter benefit being realized from the restructuring actions taken throughout the prior year. Selling, general and administrative expenses, as a percentage of revenues, decreased to 31.2% compared to 49.5% in the same three-month period a year ago, as a result of the increase in revenues and reduced spending compared to the same three-month period in the prior year.

         Restructuring and Other Charges. During the third quarter of 2002, the Company recorded a $31.5 million charge to recognize the impairment of assets in its gallium arsenide epitaxial services business in Phoenix, Arizona. The impairment charge of $31.5 million is related to long-lived assets, including deposits on fixed assets. An additional $3.1 million charge related to a write-down of gallium arsenide inventories is included in cost of revenues. All of the impaired assets are in the Technologies segment.

         Operating Loss. The Company generated an operating loss of $39.0 million in the quarter ended September 30, 2002, compared to an operating loss of $15.9 million in the same prior year quarter. The increased loss in the third quarter of 2002 reflects the effects of the $34.6 million impairment charge in the Company’s gallium arsenide epitaxial services business discussed above, which was partially offset by better operating performance in both segments of the business due to increased sales volumes and reduced selling, general and administrative spending. Materials operating income increased to $4.9 million for the three months ended September 30, 2002 compared to an operating loss of $1.0 million in the same quarter a year ago, due to increased sales volumes across product lines in this segment. Technologies generated an operating loss for the three

16


Table of Contents

months ended September 30, 2002 of $12.4 million, compared to an operating loss of $13.0 million for the same three-month period a year ago. Excluding the $3.1 million inventory write down in the gallium arsenide expitaxial services business, Technologies generated an operating loss of $9.3 million, reflecting improved but still-depressed demand for semiconductor capital equipment and depressed demand and over capacity in the thin film deposition services product lines, compared to the same quarter a year ago.

         Interest and Other Income (Expense), Net. Interest and other income (expense) decreased to a loss of approximately $1.1 million in the quarter ended September 30, 2002 from a gain of approximately $1.6 million in the same quarter a year ago. The third quarter of 2001 includes a $1.1 million gain from the sale of available-for-sale securities, partially offset by a write down of approximately $0.4 million to recognize an other-than-temporary decline in fair value of other available-for-sale securities. Interest income increased in the third quarter of 2002 by $0.3 million to $1.2 million compared to $0.9 million in the third quarter of 2001, despite the significantly higher cash and marketable securities balances, mainly as a result of significantly lower effective interest rates versus the prior year. Interest expense increased from approximately zero in the third quarter of 2001 to $1.5 million in the third quarter of 2002 due mainly to debt service costs related to the Company’s $115.0 convertible subordinated notes issued in the fourth quarter of 2001.

         Income Taxes. In the third quarter of 2002, the income tax benefit was $15.0 million, compared to an income tax benefit of $5.2 million for the same quarter a year ago. The increase in the benefit was mainly the result of the Company’s increased loss before income taxes in the quarter ended September 30, 2002. The effective tax rate for the three months ended September 30, 2002 was 37.3%. The effective tax rate for the three months ended September 30, 2001 was 36.6%. The change in the effective tax rate is primarily the result of the effect of permanent tax benefits on operating losses. As of September 30, 2002, the Company has a net deferred tax asset on its balance sheet of $15.1 million, primarily due to temporary differences and tax credits, which are anticipated to be used to offset future taxable income. The Company expects to generate sufficient taxable income in the coming years (approximately $43.0 million) to realize the deferred tax assets as the semiconductor industry recovers from the present downturn.

         Net Loss per Share. Net loss per share-assuming dilution was $0.84 in the third quarter of 2002, compared to a net loss per share-assuming dilution of $0.30 in the third quarter of 2001. On a pro-forma basis, excluding the impairment charge recognized in the third quarter of 2002, the net loss was $3.1 million or $0.10 per diluted share. On a pro-forma basis, excluding restructuring and special charges, the net loss was $6.1 million or $0.21 per diluted share in the third quarter of 2001. Weighted average shares outstanding-assuming dilution was 29.9 million for the third quarter of 2002 compared to 29.6 million in the same period in 2001. The difference in weighted average shares outstanding is primarily the result of the exercise of employee stock options and employee stock purchase plan shares.

Comparison of Nine Months Ended September 30, 2002 and 2001

         Revenues. Total revenues decreased 8.0% to approximately $158.2 million in the nine months ended September 30, 2002 from approximately $172.0 million in the same nine-month period in 2001. The decrease in revenues was primarily attributable to significant volume declines in the first quarter of 2002 compared to the first quarter of 2001, due to the effects of the downturn in the semiconductor industry, specifically within the Technologies segment. The Materials

17


Table of Contents

segment revenues were up approximately 11.1% to $98.0 million in the first nine months of 2002 compared to $88.3 million in the same nine-month period a year ago, primarily as a result of increased sales volumes in the SDS®, high purity packaging, and advanced interconnect device materials product lines. Revenues declined 28.2% in the Technologies segment in the nine-month period ended September 30, 2002 to $60.2 million from $83.8 million in the same nine-month period of 2001. The significant revenue decline in the Technologies segment is largely attributable to the downturn in worldwide semiconductor equipment spending and the downturn in the global telecommunications industry, which caused revenue declines in ATMI’s environmental treatment equipment and thin film deposition services product lines, respectively.

         Gross Profit. Gross profit decreased 21.9% to $59.5 million in the first nine months of 2002 compared to $76.1 million in the same nine-month period a year ago, reflecting the revenue decline in the first three months of 2002 compared to the same period of 2001. Gross margin in the nine-month period ended September 30, 2002 was 37.6% of revenues compared to 44.2% in the same nine-month period a year ago. Excluding special charges related to inventory write-downs of $4.2 million and $1.7 million in the nine-month periods ended September 30, 2002 and 2001, respectively, gross margins were 40.2% and 45.2%. The decline in gross profit was primarily attributable to steep volume declines in the life safety equipment and thin film deposition services product lines, which led to lower fixed overhead cost absorption within these product lines. As part of ATMI’s business realignment efforts that it announced and executed during the course of 2001, ATMI consolidated several of its formerly autonomous business units, and certain engineering and support activities were redirected to provide field service, warranty and other customer and maintenance services which are classified as cost of revenues instead of research and development. If the engineering and support activities had been redirected to cost of revenues in the first nine months of 2001, gross margin would have been 42.0% rather than 44.2%. Alternatively, had these costs not been redirected, gross margin would have been 39.9% in the nine-month period ended September 30, 2002 rather than 37.6%, as reported.

         Research and Development Expenses. Research and development expenses decreased 4.7% to approximately $22.6 million in the nine months ended September 30, 2002 from approximately $23.7 million in the same nine-month period of 2001. The decrease in spending in the first nine months of 2002 is mainly attributable to the redirection of certain engineering and support activities, as discussed above, compared to the same period of 2001. If these engineering and support activities had not been redirected in the first nine months of 2002, research and development expense would have increased 10.9% compared to the first nine months of 2001. As a percentage of revenues, research and development expenses increased to 14.3% in the nine months ended September 30, 2002 from 13.8% in the same nine-month period of 2001, primarily as a result of the significant decline in revenues during this period. Despite the semiconductor industry downturn and weakened business performance in both segments of the business, ATMI continued R&D spending on targeted programs to ensure that it has the products its customers need for future generation chip manufacturing processes, with a particular emphasis on advanced interconnect manufacturing process and materials development.

         Selling, General and Administrative Expenses. Selling, general and administrative expenses decreased 13.5% to approximately $49.8 million in the nine months ended September 30, 2002 from approximately $57.5 million in the same nine-month period in 2001. The decrease is a direct result of the restructuring initiatives that were initiated in the early part of 2001, and that were implemented throughout 2001. Selling, general and administrative expenses as a percentage of

18


Table of Contents

revenues decreased to 31.5% in the nine months ended September 30, 2002, compared to 33.4% in the same nine-month period a year ago, primarily as a result of the cost reductions realized as a result of the restructuring actions taken in 2001.

         Restructuring and Other Charges. Operating results for the first nine months of 2002 reflect the effect of a $31.5 million charge to recognize the impairment of assets in the gallium arsenide business in Phoenix, Arizona. An additional $3.1 million charge related to a write-down of gallium arsenide inventories is included in cost of revenues. Operating results for the first nine months of 2001 include a $14.0 million charge for severance and other costs associated with restructuring initiatives. The 2001 charge includes costs related to plant closings, lease termination fees, and various other assets and working capital write-offs or write-downs. An additional $0.6 million charge related to a write down of inventory is included in cost of revenues for the nine-month period ended September 30, 2001.

         Operating Loss. The Company generated an operating loss of $44.5 million in the first nine months ended September 30, 2002, compared to an operating loss of $19.2 million in the same prior year period. In the first nine months of 2002, operations, excluding the $34.6 million impairment charge discussed above, generated a loss of $9.8 million, compared to an operating loss in the first nine months of 2001 of $1.0 million, excluding the restructuring charge of $14.0 million and special charges related to inventory and accounts receivables write downs of $1.7 million and $2.5 million, respectively. The decrease in the first nine months of 2002 reflects the effects of the semiconductor industry demand downturn and its effect on coverage of ATMI’s cost base compared to the same period a year ago. Materials operating income for the nine months ended September 30, 2002 increased 28.0% to $17.1 million from $13.4 million in the same nine-month period a year ago, as a result of increased sales volumes and cost benefits from the restructuring actions initiated in 2001. The Technologies segment experienced an operating loss for the nine months ended September 30, 2002 of $30.0 million, compared to an operating loss of $18.5 million for the same nine-month period a year ago. Excluding the $3.1 million write-down related to inventories in our gallium arsenide expitaxial services business, Technologies generated an operating loss of $26.9 million for the nine months ended September 30, 2002. The downturn in the semiconductor industry, particularly in the equipment sector, has had a significant impact on the operations of the Technologies segment, due to the high concentration of equipment sales in this segment and overcapacity in the thin film deposition services product line.

         Interest and Other Income, Net. Interest and other income decreased to a loss of approximately $1.4 million in the nine-month period ended September 30, 2002 from income of approximately $10.9 million in the same nine-month period a year ago. The first nine months of 2002 includes a $1.0 million gain from the sale of available-for-sale securities, offset by writedowns of $0.4 million for other-than-temporary declines in fair value of other available-for-sale securities. The first nine months of 2001 includes the positive impact of a settlement of certain patent litigation, net of related expenses, and a $2.6 million gain from the sale of available-for-sale securities, partially offset by a writedown of $0.4 million for an other-than-temporary decline in fair value of available-for-sale securities. Interest income remained flat at $3.7 million in the first nine months of 2002 compared to the first nine months of 2001, despite higher cash and marketable securities balances, primarily as a result of the decline in market interest rates. Interest expense increased to $5.2 million in the first nine months of 2002 compared to $0.2 million in same period a year ago, due mainly to debt service costs related to the Company’s $115.0 million convertible subordinated notes issued in the fourth quarter of 2001.

19


Table of Contents

         Income Taxes. In the first nine months of 2002, the income tax benefit was $17.0 million, compared to an income tax benefit of $3.1 million in the first nine months of 2001. The increase in the benefit was the result of the Company’s increased operating losses. The effective tax rate for the nine-month period ended September 30, 2002 was 37.0%, compared to an effective tax rate of 37.8% for the comparable period a year ago. The change in the effective tax rate is primarily the result of the effect of permanent tax benefits on operating losses. As of September 30, 2002, the Company has a net deferred tax asset on its balance sheet of $15.1 million, primarily due to temporary differences and tax credits, which are anticipated to be used to offset future taxable income. The Company expects to generate sufficient taxable income in the coming years (approximately $43.0 million) to realize the deferred tax assets as the semiconductor industry recovers from the present downturn.

         Net Loss per Share. Net loss per share-assuming dilution was $0.97 in the nine months of 2002, compared to a net loss per share-assuming dilution of $0.17 in the first nine months of 2001. On a pro-forma basis, excluding the impairment charge, the net loss was $6.9 million or $0.23 per diluted share for the nine months ended September 30, 2002. On a pro-forma basis, excluding restructuring and special charges, net income was $1.7 million or $0.06 per diluted share in the first nine months of 2001. Weighted average shares outstanding-assuming dilution was 29.9 million for the first nine months of 2002 compared to 29.6 million for the first nine months of 2001. The difference in weighted average shares outstanding is primarily the result of the exercise of employee stock options and employee stock purchase plan shares.

Liquidity and Capital Resources

         To date, the Company has financed its activities through cash from operations, the sale of equity, external research and development funding, and various lease and debt instruments. The Company’s working capital decreased to $225.4 million at September 30, 2002 from $255.3 million at December 31, 2001.

         Net cash used by operations was approximately $0.2 million for the nine-month period ended September 30, 2002, compared to cash provided by operations of approximately $24.2 million during the same nine-month period of 2001. The operating loss incurred in the first nine months of 2002 included the impairment charge related to the gallium arsenide epitaxial services business, but it did not have any cash impact in the period. The reduction in net cash from operations resulted primarily from unfavorable changes in working capital versus the same period a year ago, and the effect of increased deferred tax assets and income taxes receivable as a result of the increased operating losses.

         Net cash used by investing activities was $103.3 million during the nine months ended September 30, 2002, compared to $100.1 million during the same nine-month period a year ago. Capital expenditures were $30.8 million and $58.1 million for the nine-month periods ended September 30, 2002 and 2001, respectively, with significant capital spending in the first nine months of 2001 primarily related to construction of a new liquid materials manufacturing facility in Burnet, Texas and installation of compound semiconductor gallium arsenide epitaxial process capacity at the Company’s facility in Phoenix, Arizona, which was subsequently written down in the third quarter of 2002. During the first nine months of 2002, the Company made strategic investments of $5.0 million to acquire copper delivery and abatement product lines and rights to a

20


Table of Contents

copper electrochemical deposition management system. During the first nine months of 2001, the Company paid $8.5 million for certain equity investments in two strategic partners for the development of advanced materials. During the first nine months of 2002 and 2001, respectively, the Company purchased $68.7 million and $36.6 million of marketable securities, consisting primarily of short-term corporate and municipal debt obligations.

         Net cash used by financing activities was $15.9 million in the first nine months of 2002 and net cash provided by financing activities was $11.5 million during the first nine months of 2001. During the nine-month period ended September 30, 2001, the Company entered into a $20.0 million bank financing agreement for the purchase of additional silicon epitaxial capacity, of which approximately $13.5 million was outstanding as of December 31, 2001. As allowed under the terms of the $20.0 million bank financing agreement and the capital lease obligations, during the first nine months of 2002, the Company paid down the entire amounts outstanding on the bank financing agreement, and approximately $5.1 million of capital lease obligations, in order to reduce the weighted average interest rate on indebtedness. During the first nine months of 2002 and 2001, the Company received net proceeds from the exercise of stock options and employee stock purchase plan shares of $4.2 million and $2.2 million, respectively.

         ATMI believes that its existing cash and cash equivalents and marketable securities balances, existing sources of liquidity, available lines of credit, and anticipated funds from operations will satisfy its projected working capital and other cash requirements at least through the end of 2003.

         Management believes the level of financing resources available to ATMI is an important competitive factor in its industry, and management may seek additional capital prior to the end of 2003. Additionally, management considers, on a continuing basis, potential acquisitions of technologies and businesses complementary to ATMI’s current business, which may require the use of current cash balances and additional capital. There are no present agreements with respect to any such acquisitions. However, any such transactions may affect ATMI’s future capital needs.

Forward-Looking Statements

         The statements contained in this report which are not historical are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of forward-looking statements include, without limitation, statements by ATMI regarding financial projections, expectations for demand and sales of new and existing products, market and technology opportunities, business strategies, business opportunities, objectives of management for future operations and semiconductor industry and market segment growth. In addition, when used in this report, the words “anticipate,” “plan,” “believe,” “estimate,” “expect” and similar expressions as they relate to the Company or its management are intended to identify forward-looking statements. All forward-looking statements involve risks and uncertainties. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements as a result of certain factors including, but not limited to, changes in the pattern of semiconductor industry demand, the markets for or customer interest in the products of ATMI, product and market competition, delays or problems in the development and commercialization of products, technological changes affecting the competencies of ATMI, problems or delays associated with its restructuring activities, problems or delays in integrating acquired operations or businesses into ATMI, unanticipated internal and/or

21


Table of Contents

third-party delays and other factors listed from time to time in ATMI’s filings with the Securities and Exchange Commission. The cautionary statements made in this report should be read as being applicable to all related forward-looking statements wherever they appear in this report.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

         Interest Rate Risk. As of September 30, 2002, the Company’s cash and cash equivalents included money market securities, municipal bond obligations and commercial paper. Due to the relatively short maturity of the Company’s investment portfolio, an immediate 10% change in interest rates would not have a material effect on the fair value of the Company’s portfolio; therefore, the Company does not expect its operating results or cash flows to be affected to any significant degree by the effect of a sudden change in market interest rates on the Company’s securities portfolio. As of September 30, 2002, a majority of the Company’s debt carried fixed interest rates; therefore, the Company does not expect its operating results or cash flows to be significantly affected by the effect of a sudden change in market interest rates.

         Foreign Currency Exchange Risk. A substantial portion of the Company’s sales are denominated in U.S. dollars and, as a result, the Company has relatively minimal exposure to foreign currency exchange risk with respect to sales made. This exposure may change over time as business practices evolve and could have a material impact on the Company’s financial results in the future. The Company does not use forward exchange contracts to hedge exposures denominated in foreign currencies or any other derivative financial instruments for trading or speculative purposes. The Company believes that an immediate 10% change in exchange rates would not have a material impact on the Company’s future operating results or cash flows.

Item 4. Controls and Procedures

         As of the date of this filing, an evaluation was performed under the supervision and with the participation of the Company’s management, including its CEO and CFO, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on that evaluation, the Company’s management, including its CEO and CFO, concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2002. There have been no significant changes in the Company’s internal controls or in other factors that could significantly affect internal controls subsequent to September 30, 2002.

         Reference is made to the Certifications of the CEO and CFO about these and other matters following the signature page of this report.

22


Table of Contents

PART II- OTHER INFORMATION

Item 1. Legal Proceedings

         In the normal course of business, ATMI is involved in various lawsuits and claims. Although the Company cannot determine the ultimate outcome of any of these legal proceedings at this time, management, including internal counsel, does not believe that the outcome of these proceedings, individually or in the aggregate, will have a material adverse effect on ATMI’s financial position or overall trends in results of operations.

Item 6. Exhibits and Reports on Form 8-K

  (a)   Exhibits

  99   Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

  (b)   Reports on Form 8-K
 
      None.

23


Table of Contents

SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

             
        ATMI, Inc.    
November 11, 2002            
    By   /s/ Eugene G. Banucci    
       
   
    Eugene G. Banucci, Ph.D.,
Chief Executive Officer, Chairman of the
Board and Director
   
             
    By   /s/ Daniel P. Sharkey    
       
   
    Daniel P. Sharkey, Vice President, Chief
Financial Officer and Treasurer (Chief
Accounting Officer)
   

24


Table of Contents

CERTIFICATIONS

I, Eugene G. Banucci, certify that:

  1.   I have reviewed this quarterly report on Form 10-Q of ATMI, Inc. (the “Company”);
 
  2.   Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
  3.   Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this quarterly report;
 
  4.   The Company’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Company and have:

  a)   designed such disclosure controls and procedures to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
  b)   evaluated the effectiveness of the Company’s disclosure controls and procedures as of the date of this filing (the “Evaluation Date”); and
 
  c)   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

  5.   The Company’s other certifying officers and I have disclosed to the Company’s auditors and the audit committee of the Company’s board of directors:

  a)   all significant deficiencies and material weaknesses in the design or operation of internal controls which could adversely affect the Company’s ability to record, process, summarize and report financial data and have identified for the Company’s auditors any material weaknesses in internal controls; and
 
  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls; and

25


Table of Contents

  6.   The Company’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

         
November 11, 2002        
    /s/ Eugene G. Banucci    
   
   
    Eugene G. Banucci, Ph.D.,
Chief Executive Officer, Chairman of the
Board and Director
   

26


Table of Contents

I, Daniel P. Sharkey, certify that:

  1.   I have reviewed this quarterly report on Form 10-Q of ATMI, Inc. (the “Company”);
 
  2.   Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
  3.   Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this quarterly report;
 
  4.   The Company’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Company and have:

  a.   designed such disclosure controls and procedures to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
  b.   evaluated the effectiveness of the Company’s disclosure controls and procedures as of the date of this filing (the “Evaluation Date”); and
 
  c.   presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

  5.   The Company’s other certifying officers and I have disclosed to the Company’s auditors and the audit committee of the Company’s board of directors:

  a.   all significant deficiencies and material weaknesses in the design or operation of internal controls which could adversely affect the Company’s ability to record, process, summarize and report financial data and have identified for the Company’s auditors any material weaknesses in internal controls; and
 
  b.   any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls; and

27


Table of Contents

  6.   The Company’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

         
November 11, 2002        
    /s/ Daniel P. Sharkey    
   
   
    Daniel P. Sharkey, Vice President,
Chief Financial Officer and Treasurer
(Chief Accounting Officer)
   

28